These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10540047)

  • 1. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis.
    Törkvist L; Thorlacius H; Sjöqvist U; Bohman L; Lapidus A; Flood L; Agren B; Raud J; Löfberg R
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1323-8. PubMed ID: 10540047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.
    Vrij AA; Jansen JM; Schoon EJ; de Bruïne A; Hemker HC; Stockbrügger RW
    Scand J Gastroenterol Suppl; 2001; (234):41-7. PubMed ID: 11768560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.
    Vrij AA; Oberndorff-Klein-Woolthuis A; Dijkstra G; de Jong AE; Wagenvoord R; Hemker HC; Stockbrügger RW
    J Thromb Thrombolysis; 2007 Oct; 24(2):175-82. PubMed ID: 17308963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials.
    Chande N; MacDonald JK; Wang JJ; McDonald JW
    Inflamm Bowel Dis; 2011 Sep; 17(9):1979-86. PubMed ID: 21618363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.
    Dotan I; Hallak A; Arber N; Santo M; Alexandrowitz A; Knaani Y; Hershkoviz R; Brazowski E; Halpern Z
    Dig Dis Sci; 2001 Oct; 46(10):2239-44. PubMed ID: 11680603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.
    Bloom S; Kiilerich S; Lassen MR; Forbes A; Leiper K; Langholz E; Irvine EJ; O'Morain C; Lowson D; Orm S
    Aliment Pharmacol Ther; 2004 Apr; 19(8):871-8. PubMed ID: 15080848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
    de Bièvre MA; Vrij AA; Schoon EJ; Dijkstra G; de Jong AE; Oberndorff-Klein Woolthuis AH; Hemker HC; Stockbrügger RW
    Inflamm Bowel Dis; 2007 Jun; 13(6):753-8. PubMed ID: 17260365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
    Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.
    Pastorelli L; Saibeni S; Spina L; Signorelli C; Celasco G; de Franchis R; Vecchi M
    Aliment Pharmacol Ther; 2008 Sep; 28(5):581-8. PubMed ID: 18700898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study.
    Naganuma M; Aoyama N; Tada T; Kobayashi K; Hirai F; Watanabe K; Watanabe M; Hibi T
    J Gastroenterol; 2018 Apr; 53(4):494-506. PubMed ID: 28779419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
    Shen J; Ran ZH; Tong JL; Xiao SD
    Aliment Pharmacol Ther; 2007 Sep; 26(5):653-63. PubMed ID: 17697199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.
    Celasco G; Papa A; Jones R; Moro L; Bozzella R; Surace MM; Naccari GC; Gasbarrini G
    Aliment Pharmacol Ther; 2010 Feb; 31(3):375-86. PubMed ID: 19891665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m leukocyte imaging for evaluating disease severity and monitoring treatment response in ulcerative colitis: comparison with colonoscopy.
    Aburano T; Saito Y; Shuke N; Ayabe T; Kohgo Y; Sato J; Ishikawa Y
    Clin Nucl Med; 1998 Aug; 23(8):509-13. PubMed ID: 9712382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
    Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
    J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium Tc 99m hexamethyl propylene amine oxine leukocyte scintigraphy in patients with ulcerative colitis: correlation with clinical, biologic, endoscopic, and pathologic intensity, and local release of interleukin 8.
    Guimbaud R; Beades E; Chauvelot-Moachon L; Quartier G; Gaudric M; Bertrand V; Cellier C; Vidon N; Devaux JY; Richard B; Couturier D; Chaussade S
    Gastrointest Endosc; 1998 Nov; 48(5):491-6. PubMed ID: 9831837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis.
    Kanke K; Hoshino M; Tominaga K; Nakano M; Terano A; Hiraishi H
    Blood Purif; 2007; 25(4):370-6. PubMed ID: 17785966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.